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Abstract
Introduction: Restoring defects of load-bearing connective tissues such as articular cartilage resulting from traumas, degenerative or age-related diseases remains a 
significant clinical challenge for clinicians due to the limited inherent repair capacity of articular cartilage. Tissue engineering has emerged as a potential alternative 
to the traditional surgical techniques, as it can be effectively used to regenerate bone, cartilage and the bone-cartilage interface. Several scaffold strategies have been 
developed and evaluated for osteochondral defect repair. 
Materials and methods: The classes of polymers (scaffold-based proteins, scaffold-base polysaccharides and synthetic scaffolds) and Hydrogels have been reviewed 
trough literature and market search. The study focused on their respective properties and analyzed advantages and disadvantages of each of them. 
Discussion: Clinical studies demonstrated improved cartilage regeneration thanks to the implantation of biomaterials after bone marrow stimulation. New cartilage 
can be engineered in vivo by transplanting chondrocytes seeded into a three-dimensional scaffold and this novel scaffold has mechanical properties that can be 
comparable to native cartilage and could be used to repair large osteochondral joints defects. Anyway, there is still space for improvement regarding clinical outcome 
and tissue quality.
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Introduction
Restoring defects of load-bearing connective tissues such as 
articular cartilage resulting from traumas, degenerative or age-related 
diseases remains a significant clinical challenge for clinicians due to 
the limited inherent repair capacity of articular cartilage. Articular 
cartilage defects are increasingly common among the adult population 
related to the Osteoarthritis (OA) that throughout the years may lead 
to pain, reduced joint function and disability among affected patients 
[1]. Articular cartilage is a specialized tissue that covers joint surfaces 
and provides a low-friction and load-bearing surface for a smooth 
motion of joints. Healthy articular cartilage is able to withstand 
decades of repetitive loading that regularly exceeds several times body 
weight. Its unique behavior is attributed to the multiphasic nature of 
the extracellular matrix (ECM), which can be described as a charged, 
porous-permeable solid that is saturated with water and dissolved 
ions. Collagen, the primary component within the solid phase of the 
ECM, forms a fibrous network that is predominantly responsible for 
determining the tensile and shears mechanical characteristics of the 
tissue. Intermingled throughout this collagen microstructure are large, 
negatively charged proteoglycan macromolecules that give cartilage the 
ability to imbibe water and swell the tissue in an attempt to maintain 
physicochemical equilibrium. This swelling effect, which is constrained 
by the collagen network, pressurizes the tissue and contributes 
significantly to its load bearing and low-friction properties.
The structure and function of this tissue can be compromised by 
degeneration, advanced age, female sex, obesity, repeated joint micro-
injuries, or injection of chondrotoxic agents. Due to its avascular 
nature, damaged cartilage tissue does not heal spontaneously and it 
remains a challenge to fully restore tissue function. The poor capacity 
for self-repair of chondral defects has resulted in the development of a 
large variety of treatment approaches.
Bone marrow stimulation techniques such as microfracture and 
subchondral drilling involve the surgical placement of holes that 
connect the debrided cartilage lesion to the underlying bone marrow 
stroma to recruit pluripotential cells capable of repairing soft and hard 
tissues. Increased recruitment of marrow-derived stromal cells was 
linked to improved cartilage repair in rabbit models. Chondrogenic foci 
arising from subchondral bone progenitors have also been identified 
as the main source of cartilaginous repair tissue for the chondral 
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defects in animal models. Microfracture surgery may be applied to 
treat cartilage defects. During the procedure the subchondral bone is 
perforated, allowing bone marrow-derived mesenchymal stem cells to 
migrate towards the defect site and form new cartilage [2]. The latter 
strategy, also known as bone marrow stimulation including bone 
marrow stromal cells (BMSCs) and biodegradable scaffolds, is relatively 
simple, minimally invasive and inexpensive. Tissue engineering and 
regenerative medicine may improve the outcome of microfracture 
surgery. Filling the subchondral defect with a biomaterial may provide 
a template for the formation of new hyaline cartilage tissue [3,4].
Tissue engineering has emerged as a potential alternative as it 
can be effectively used to regenerate bone, cartilage and the bone-
cartilage interface. Several scaffold strategies, such as single phase, 
layered, and recently graded structures have been developed and 
evaluated for osteochondral defect repair. Applying biomaterial 
scaffold whose primary function is to control the shape and volume 
of the newly formed tissue, it is possible to facilitate , at the same time, 
the attachment, proliferation, and differentiation of embedded cells [5-
7]. In addition to influencing the shape and metabolic activity of the 
engineered construct, scaffolds must also be capable of withstanding 
the mechanical environment of the native tissue that has to be replaced.
Materials and methods





Natural materials have properties such as biodegradability and 
bioactivity, fundamental for the good integration with the host tissue. 
They also promote the growth and proliferation of cells.
The biomaterials can be based on proteins or polysaccharides.
The synthetic materials offer good control over the composition and 
consistency of the matrix, have mechanical properties and adjustable 
biodegradability and involve low cost of synthesis. Compared with 
natural materials, their degradation products may be harmful to the 
body. We distinguish the polyesters, which include poly (hydroxy 
acids) and poly (idrossialcanoati), and polyurethanes.
Hydrogels are constituted by viscous polymers obtained by 
covalent or ionic bonds between macromolecules hydrophilic. The 
hydrogels physically entrap the cells inside of the structure, which 
are distributed evenly. Their hydrophilicity reproduces the hydrated 
nature of the cartilage and allows to minimize the surgical invasiveness, 
as these materials are easily injectable. Listed in table 1 the classes of 
polymers reviewed in this manuscript. 
Scaffold-based proteins
MeRG - Biocollagen® (Biotech)
Description: It is a resorbable membrane for guided tissue 
regeneration, used in the one-step techniques.
Composition: It consists of type I collagen lyophilized, 
hypoallergenic and extracted from equine Achilles tendon (Type I> 
95%, Type III <5%, glycosaminoglycans 2,75 mg / g).
Preparation: It is advisable to rehydrate the product with sterile 
saline for 3-5 minutes
Sterilization: the product is disposable and non-sterilizable.
Property: It consists of a microfibrillar collagen membrane, non-
friable and resistant to traction and torsion.
The membrane has a smooth side and a rough-fibrillar side that 
allows fixing the matrix with fibrin glue. The interaction of collagen 
with thrombocytes is important for blood coagulation as the link with 
the platelet integrin determines the degranulation of the platelets 
themselves, and the “release” of factors activating the coagulation 
cascade with the formation of the fibrin lattice. The grid formed by 
Class of Polymers Material Advantages Disadvantages
Based on Protein Polymers Fibrin: From fibrinogen degradation, starring role in coagulation
Lower toxicity
Low cost
Promotion of adhesion and migration of cells
Poor biomechanical strength
Collagen: Main component of the ECM, it 
allows cells to maintain their phenotype.
Help adhesion of cells
Biodegradable
Physical and chemical variable properties
Variable degradation
Based on Polysaccharide Polymers
Hyaluronic acid: It maintains the degree of 
hydration, firmness, plasticity and viscosity 
of cartilage.
Low toxicity
Supporting migration of mesenchymal stem 
cells and epithelial cells
Fill irregular defects
Poor biomechanical strength
Alginate: From algae, it absorbs water 
quickly.




Not suitable for long-term implants
Synthetic Polymers PLA: Chiral molecule used in many commercial products.
High stress resistance
High Young's modulus
Possibility of synthesizing in different forms
His depolymerization require excessive 
heating
Local acidosis caused by biodegradation 
products
PGA: Synthesized by condensation of 




His product of degradation (glycolic acid) 
exists in nature
Rapid degradation
His product of degradation (glycolic acid) 
causes acidosis
PCL: Amorphous structure, suitable to the 
release of drugs
Good osteoinductive potential
Non- toxic degradation products
Good mechanical properties
Acid residues as a result of degradation





Amorphous, so it’s difficult to use.
Table 1. Classes of Polymers and respective properties.
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to the tissue biomechanics. In addition, 3D Novocart induces the 
regeneration of cartilage through the growth and differentiation factors.
Indications: The cartilage defects treated with 3D Novocart derive 
from osteochondritis dissecting or trauma of the bearing regions of the 
joints. It is indicated in young patients (but not younger than 16 years) 
to avoid possible secondary damage such as premature osteoarthritis.
Contraindications: The use of 3D Novocart is contraindicated 
in patients with known hypersensitivity to collagen. It is also 
contraindicated in cases of cartilage defects caused by inflammatory 
diseases or massive degeneration. The defect must not be more 
extensive than 14 cm2 or deeper than 7 mm.
MaioRegenTM – Biojoint System
Description: MaioRegen represents a new therapeutic concept 
inspired by nature that improves the regeneration of bone and cartilage. 
It is a three-dimensional matrix that mimics the osteo-cartilaginous 
tissue, composed of subchondral bone and cartilage. Easy to use and 
apply in one-step procedures, MaioRegen is available in 3,5x3,5x0,6 
and 5x5x0,6 cm formats.
Composition: It is presented as a multi-layer and monolithic 
scaffold: the surface layer is composed of equine collagen type I and 
reproduces the cartilage tissue, while the deepest layer consists of 
hydroxyapatite, rich in magnesium (Mg-HA), and simulates the 
structure subchondral. The intermediate layer, composed of Mg-HA 
and collagen, reproduces the interface between the two fabrics.
Property:
- Biomimetics: The particular chemical composition and 
structure makes MaioRegen a completely biomimetic scaffold. The 
“chemical” biomimetics is the result of the combination of collagen 
macromolecules and nanocrystals of MgHA, which is done through an 
innovative nucleation mechanism. The “structural” biomimetics is due 
to the characteristic orientation of the collagen fibers, arranged as in 
the human osteochondral tissue.
- Hydration: MaioRegen can quickly absorb body fluids (water 
absorption: 75%) for its high porosity and hydrophilicity. The thickness 
of the membrane provides a solid stabilization, without any suture or 
other fixation methods.
-Flexibility: MaioRegen is flexible and elastic and it is adapting 
with the anatomical curvature of the application site.
- Conformability: MaioRegen can be easily adapted during surgery 
to the size of the defect and can also be used for the treatment of 
extended lesions.
- Biodegradability: The chemical composition of biomimetic 
membrane allows its complete degradation, thus facilitating the 
regenerative processes.
Activity: The porous structure and the chemical composition of 
MaioRegen improve chemotaxis cell. Progenitor cells derived from 
bone marrow adhere to collagen fibers, colonizing the scaffold. At this 
point, the cells are able to proliferate, differentiate and synthesize the 
cartilaginous and bone matrix in accordance with the organic mineral 
gradient present in the scaffold.
Indications: MaioRegen is indicated in every case it is necessary to 
restore the connective tissue in the joints, in particular in the treatment 
of traumatic, post-traumatic or degenerative osteo-chondral lesions, or 
fibrin retains elements of the corpuscular part forming the clot that 
induce migration of fibroblasts.
Activity: MeRG favors the cell surface adhesion and holds 
mesenchymal cells, preventing the latter from escaping into the joint 
cavity.
Metabolization: MeRG derived from natural equine collagen, so 
it’s reabsorbed spontaneously in 60/90 days. 
Contraindications: known hypersensitivity to collagen.
Chondro-Gide® (Geistlich) 
Description: It’s a double-layer collagen matrix; it’s available in 
sizes 20x30 mm, 30x40 mm and 40x50 mm.
Composition: It is composed of type I and III collagen and it’s 
presented as a collagen matrix bilayer. The compact layer prevents the 
spreading of mesenchymal stem in the joint and protects mechanical 
stress; the porous layer is made of dispersed collagen fibers that support 
the engraftment of the cells.
Preparation: It is necessary rehydrate the product with sterile 
physiological solution for 3-5 minutes.
Sterilization: The product is disposable and non resterilizable. 
Property: Chondro-Gide is made by porcine collagen, which is 
naturally degraded into oligopeptides first and then into individual 
amino acids by collagenases, gelatinases and proteinases. Finally, it is 
easy to handle and prevents intra-articular bleeding.
Activity: The functional principle of Microfracturing is based on 
multipotent mesenchymal stem cells, cytokines and growth factors 
released by the subchondral bone. 
The clot formed as a result of hemorrhage is stabilized by the matrix 
and the fibrin glue. At this point, Chondro-Gide constitutes a suitable 
support structure to promote chondrogenic differentiation of cells and, 
in combination with fibrin glue, stimulates chondrocytes to increase 
the deposit of proteoglycans.
Contraindications: The use of Chondro-Gide is contraindicated in 
patients with known hypersensitivity to collagen.
Novocart 3D – AesculapOrthopaedics (BBraun) 
Description: It is a two-phase matrix used in 3D- ACT therapy 
(autologous chondrocyte transplantation tridimensional) to fill 
cartilage defects.
Composition: The material consists of a membrane coating (A) 
applied on the surface of a spongy structure with interconnected pores 
(A ‘and A’ ‘); the sponge and the membrane are solidly connected to 
one another. The matrix, based on type II collagen and aggrecan, is 
combined with physiological components of hyaline cartilage and 
subsequently autologous chondrocytes are added.
Preparation: The production is possible to use after three weeks 
after removal of the hyaline cartilage of the patient.
Property: Novocart-3D has high biomimetic and reduces the 
presence of inflammatory mediators (such as interleukin-1). Finally, 
as it uses an autogenous serum, avoids the use of antibiotics and 
antifungals.
Activity: The matrix keeps the cultured cells vital and synthesizes 
the proteins present in cartilage, which offer a decisive contribution 
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if caused by osteochondritis dissecans; in III-IV grade lesions according 
to the Outbridge’s classification and in single or multiple focal lesions.
Contraindications: MaioRegen should not be used in patients 
with advanced arthritic conditions, immune disorders, infectious or 
neoplastic diseases, obesity and older than 60 years.
Neocart® (Histogenics)
Description: It is a three-dimensional matrix that is disseminated 
with patient’s cells (two-step technique). It’s used to recreate a tissue 
similar to the hyaline cartilage of the knee.
Composition: It’s composed of type I collagen extracted from 
bovine.
Preparation: The NeoCart system is realized using the chondrocytes 
of the patient, generally taken from the articular surface of the femur. 
The cells are expanded, grown into the scaffolds of collagen type 
I and then incubated in the TEP (Tissue Engeneering Processor). 
It’s designated to simulate the variation of mechanical forces and to 
reduced oxygen pressure. The incubation in this environment allows the 
chondrocytes to maintain their phenotype and to produce the proteins 
of the extracellular matrix, essential for the cartilage functionality.
Property: The system (scaffold and chondrocytes) reproduces the 
architecture of the knee articular cartilage and performs its biochemical 
functions. NeoCart is biocompatible, bioresorbable and maintains over 
time its mechanical characteristics.
Contraindications: The membrane is not indicated in patients 
with known hypersensitivity to collagen.
CaReS® (Arthrokinetics) 
Description: It is an innovative technology for the surgical 
treatment of joint injuries. It is a three-dimensional structure that 
reproduces hyaline cartilage through the autologous chondrocyte 
implantation. It is used in two-step procedures.
Composition: CaReS is a three-dimensional type I collagen-
matrix cells (made for the 99.8% of pure native collagen), on which the 
autologous chondrocytes are cultivated.
Preparation: Once the biopsy is performed, chondrocytes are 
isolated and combined with fluid matrix. After 14 days, without growth 
factors, the material is fixed in the lesion by a fibrin glue to involve the 
cartilaginous structures adjacent to the articulation.
Property: The high functionality and cellular activity allow a 
natural production of type II collagen.
CaReS has a stable form and structure and its size can be easily 
adjusted. The height and thickness can be adapted to the lesion.
Activity: It accelerates and optimizes the regeneration process of 
hyaline cartilage, through the production of type II natural collagen. 
Chondrocytes grown on Cares, in fact, are able to proliferate thanks to 
the highly bioactive support and capable of releasing growth factors.
Indications: The use of CaReS is indicated for lesions sized between 
2.5 and 10 cm2 and III and IV grade according to Outerbridge’s 
classification. It is also recommended in case of osteochondritis 
dissecans.
Contraindications: CaReS is contraindicated in case of damaged 
ligaments, rigid joints, arthrofibrosis, inflammatory processes, infectious 
diseases, metabolic disorders and in patients older than 60 years.
CartiMaix® (Matricel)
Description: CartiMaix is a biodegradable membrane used as a 
carrier in the cartilage regeneration techniques in both one-step and 
two-step techniques.
It’s available in three sizes: 25x30 mm, 30x40 mm and 40x50 mm.
Composition: The scaffold is made of porcine collagen and elastin 
and has two layers: the first one is thick and it interfaces with the joint 
space providing a protective shield; the second one is fibrous and it’s 
in contact with the cartilage defect, providing an ideal matrix for the 
cells adhesion.
Preparation: The membrane is used in one-step procedure MA-
MFX (MatrixAssisted Bone MarrowStimulation) for lesions with 
dimensions comprised between 2 and 12 cm2: the imprint of the lesion 
is taken after a diagnostic arthroscopy, using the aluminum template 
provided and then the membrane is properly shaped. The membrane 
is fixed with the fibrous side in contact with the damaged site, after 
subchondral bone perforations, through the fibrin glue. The correct 
positioning and its stability are finally verified by subjecting the 
articulation in flexion and extension movements.
The selected technique is called CACI (Collagen-covered 
Autologus chondrocyte Implantation) in case of 12 cm2 wider lesions. 
It involves two steps: the patient’s autologous chondrocytes are picked 
and expanded in the laboratory under controlled conditions to form a 
suspension, then are injected into the defect. The correct positioniting 
of the matrix is checked at the end of the procedure testing the knee 
movement.
Sterilization: The membrane is provided inside a double-sterilized 
blister, accompanied by an aluminum sterile template (40x50 mm) 
that can be employed to create the imprint of the defect and using it to 
obtain the proper shape. 
Property: Scaffold is based on collagen and elastin so it’s safe and 
biocompatible. 
Contraindications: Cartimaix is controindicate in case of known 
hypersensitivity to one of the product components.
Scaffold-based polysaccharides
Hyalofast ® (Anika)
Description: It is a biodegradable scaffolds used in the repair of 
chondral defects, through a one step procedure. It is available in 2x2 
cm and 5x5 cm sizes.
Composition: It is constituted by a single three-dimensional 
fibrous layer of HYAFF®, a benzyl ester of hyaluronic acid.
Preparation: HyaloFast system can be implanted with mini-
artrotomies. The scaffold is cut with sterile scissors and placed on the 
lesion with the help of pliers after assessing the size of the defect through 
a template. If necessary, it can be fixed by fibrin glue or sutures. Several 
layers can be used in case of very deep lesions.
Sterilization: The sterilization is obtained by means of gamma rays.
Property: HyaloFast can be adapted to the size of the lesion and 
it’s easily applied arthroscopically because it presents a bioadhesive 
nature. The degradation time is controllable and it’s bioresorbable 
because it has the natural configuration of the hyaluronic acid. Thanks 
to the absence of animal or human derivated, the risk of inflammatory 
response is reduced. 
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Activity: HyaloFast provides a biodegradable support for the 
engraftment and immobilisation in situ of mesenchymal stem cells, 
originating from the bone marrow after microfractures.
Warnings: The membrane is exclusively for surgical use, it should 
be stored in a cool, dry place (T <40 ° C) and requires immediate use 
after package opening. 
Hyalograft C® (Anika)
Description: It is an advanced therapeutic product which 
it containing patient’s cartilage cells included in 2x2 cm inserts. 
Each insert contains approximately 4x10^6 autologous and vital 
chondrocytes. It is used in two-step techniques for the damage repair 
in femoral condyles and trochlea cartilage.
Composition: Autologous chondrocytes are expanded in vitro 
and cultured on the scaffold. The scaffold is composed by a three-
dimensional structure to the fibrous layer HYAFF®, which is a esterified 
derivative of hyaluronic acid.
Preparation: A arthroscopic biopsy of healthy cartilage from 
patient’s knee is taken. The chondrocytes are isolated and expanded in 
vitro before being seeded in the scaffold of hyaluronic acid. Hyalograft 
C is then implanted by arthroscopy or arthrotomy.
Property: It is easily adaptable to the lesion size thanks to its solid 
consistency and intrinsic adhesive properties. The scaffold fibers have a 
20μm diameter and a variable pore size.
Activity: The product is suitable for surgical repair of cartilage 
defects caused by sudden or repeated micro-traumas in adults and 
young people (once the cartilage growth is completed).
Contraindications: The use of Hyalograft C is contraindicated in 
patients with known hypersensitivity to the product components.
Warnings: In January 2013 Hyalograft C was withdrawn from the 
market because of the outcome of the preliminary assessment of the 
CAT (Committee of Advanced Therapies).
Cartipatch® (Xizia Biotech) 
Description: Cartipatch is composed by a single layer of expanded 
cartilage cells combined with a hydrogel. The aim is improving the 
stability of the cells phenotype and simplify the surgical positioning. 
The scaffold has a cylindrical shape, with a smooth end to reproduce 
the cartilage surface and a cone base to facilitate the installation. The 
available diameters are 10 mm, 14 mm or 18 mm and a thickness is 4 
mm. Used in two-step techniques.
Composition: The scaffold is made combining agarose and 
alginate; alginate provides an elasticity to the matrix which improves 
the handling during the surgery.
Preparation: 200 mg of cartilage is collected arthroscopically. Cells 
are extracted through enzymatic digestion and they are grown in a 
bioreactor with the addition of autologous serum and are multiplied 
(up to about 10 million per ml). Cells are then isolated and placed 
inside an agarose and alginate gel; the suspension is molded to obtain 
the cylindrical implants of different diameters. The hydrogel grows for 
about 21 days with a growth factor and undergoes a phenotype and 
vitality test. At this point the graft is surgically implanted: A proper 
cavity should be created with a drill to accommodate the scaffold 
and then the matrix is positioned by a needle. The needle has a dual 
function: to spill the captive air in the cavity and center the defect site.
Sterilization: Obtained by autoclave.
Property: The development of Cartipatch followed the aim 
to improve the ease and speed of the surgical gesture, guarantee a 
homogeneous distribution of the cells within the lesion and absence 
of risk of grafted chondrocyte cell outdistance. The inclusion of the 
cells within a three-dimensional matrix can meet all these demands. 
Cartipatch is biocompatible (guaranteed by the absence of animal 
products) and permits the cell differentiation. This requirement is 
obtained thanks to an appropriate three-dimensional environment and 
also using an autologous serum instead of a bovine serum as a growth 
factor. The hydrogel, combined with a cell suspension, allows to model 
complex shapes at 37°C.
Cartipatch ensures a longtime vitality of the cells.
Indications: The Cartipatch system requires three-dimensional 
instruments for the different measures of matrix (10, 14 and 18 mm). 
Contraindications: Do not use Cartipatch in case of known 
hypersensitivity to one of the product components.
Synthetic scaffolds
Chondrotissue® (Biotissue)
Description: It is a medical device class III CE, used in treatments 
without autologous cells (one-step technique), for cartilage defects in 
the knee, hip or ankle. It is white-coloured, consistency is firm and 
different sizes are available (20x30x1,1 mm).
Composition: Chondrotissue is a membrane based on PGA and 
hyaluronic acid.
Preparation: The hyaluronic acid is freeze-dried with the 
polyglycolic acid (PGA) base, then packed.
Sterilization: Chondrotissue must be created in sterile conditions. 
Hyaluronic acid is used, sterilized by moist heat and felt in PGA, 
sterilized by radiation. It is a disposable product because its properties 
can be altered in a re-sterilization.
Property: The matrix is biocompatible and resorbable because of 
the PGA felt, that dissolves without residue in a few weeks in order to 
make way for the new tissue. PGA does not contain animal or human 
components and it is ideal for patients with allergies to animal protein.
Chondrotissue resurfaces and fill in the lesion and promotes the 
cartilage repair, relieves pain, and improves mobility. This scaffold 
offers maximum stability and great joint strength. Thanks to its texture, 
it can permit a hemostasis function in case of local bleeding, which can 
be occured in case of microfractures.
Indications: In order to restore the elastic properties, it is 
recommended to mix chondrotissue with autologous plasma or serum 
enriched with platelets (PRP) before implantation. If these are not 
available, the elasticity can be restored by infusion of physiological 
saline solution.
The scaffold can be molded to the size of the defect and it may be 
fixed by resorbable “pins” or suture thread. It can also be pasted on the 
defect by fibrin glue, which should be applied on the membrane edge.
Chondrotissue should be stored in a cool and dry place, protected 
from sunlight and keep away from sources of radiation.
Contraindications: Chondrotissue is contraindicated in case of 
known hypersensitivity to one of the ingredients of the product and 
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should not be used in patients who must undergo a chemotherapy and/
or radiotherapy within three weeks from implantation.
Bioseed®- C (Biotissue)
Description: BioSeed-C is constituted by a rectangular matrix 
whose length, width and thickness respectively correspond to 30 x 20 
x 2 mm, 30 x 30 x 1.1 mm, 30 x 20 x 1.1 mm or 50 x 20 x 1.1 mm. It 
contains intercommunicating cavities where 28.8 million autologous 
cells are uniformly distributed. The cells were previously isolated from 
a patient’s cartilage sample, multiplied in vitro for 3 days of culture, 
and finally fixed to the membrane fibrin (two-step technique).
Composition: The matrix is  made from a resorbable polymeric 
material of pure polyglycolic acid or from a composite of polyglactin 
910 and poly-p-dioxanone (PDS). The material is free of dyes, soft and 
elastic, and it can be flexed and cut without fraying.
Preparation: Polyglactin 910 and PDS are combined together 
using a thermoplastic process without use of additives or excipients. 
The obtained matrix has pores able of retaining the cells and promoting 
the growth.
Sterilization: BioSeed-C can be stored, after inoculation of 
autologous chondrocytes, in its sterile packaging up to the time of 
transplantation and kept inside the insulating container. The 96 hours 
of validity of the product are guaranteed at a temperature between 4 ° 
and 25 ° C.
Property: BioSeed-C replaces the cartilage defects and restore its 
functions thanks to th perfect three-dimensional chondrocytes scaffold. 
The stability of the environment stimulates these cells to differentiate. 
The major advantage is the use of the patient’s cells: BioSeed C cannot 
reject and it is therefore biocompatible and bioresorbable.
Indications: Underlying diseases must be checked before the 
blood sample. Affected cartilage must be completely removed before 
implantation, avoiding to damage the underlying bone plate. 
BioSeed-C consistency allows the transport and the application 
with tweezers or by hands, but requires occasionally immersion in 
physiological saline solution to prevent drying. The membrane must 
be shaped according to the lesion size. It can be inserted with one of 
the traditional surgical techniques and fixed with sutures, absorbable 
tacks or fibrin glue.
Contraindications: BioSeed-C is contraindicated in case of 
hypersensitivity to bovine proteins or to substances present in the 
product. It could have minimal traces of penicillin, amphotericin B and 
residues of gentamicin. BioSeed-C must not take contacts with oxidant 
substances such as iodine and H2O2 because they could denature 
proteins with heavy metals and they can be detrimental to cell viability 
and undermine the effectiveness of the product.
Hydrogel 
BioCartTMII (ProChon Biotech) 
Description: BioCart II is used in the two-step techniques for 
repairing the articular cartilage: the combination of autologous cells, 
embedded within a natural hydrogel, is a safe therapeutic approach.
Composition: The scaffold is made of fibrin and hyaluronic acid of 
human origin and it has a porous structure that allows the distribution 
of the cells.
Preparation: The hydrogel is prepared by combining a solution of 
human fibrinogen hyaluronic acid and thrombin in order to obtain the 
coagulum. It’s lyophilized (freeze-drying) to create a porous scaffold 
with open channels for seeding the cells. The autologous chondrocytes 
from healthy cartilaginous tissue are expanded by enzymatic 
degradation of collagenase and they are expanded in culture with 
autologous serum and FGF in addition. The modified chondrocytes are 
added in the scaffold and implanted into the defect site.
Property: The scaffold is made by fibrin and hyaluronic acid, 
which make the product biocompatible and biodegradable. Then 
porous structure and the channels permit the distribution of cells 
homogeneously. BioCart II can promote the repair of the entire 
cartilage layer. Moreover, the chondrocytes are endowed with a higher 
proliferation rate than non-modified cells thanks to the growth factor used.
Contraindications: BioCart II is controindicated in case of known 
hypersensitivity to one of the components of the product.
Discussion
The regeneration of damaged cartilage using implantation of 
acellular biomaterials has been widely investigated using preclinical 
models. Different outcome measures such as macroscopic and 
histological evaluation, semi-quantitative macroscopical and 
histological evaluation using scoring systems, histomorphometry, PCR 
and biochemical assays were used to assess the regenerative potential 
of implanting biomaterials. The general findings of the majority of 
the systematic review and meta-analysis are that the implantation of 
biomaterials improves cartilage regeneration compared to non-treated 
osteochondral defects [8]. In general, clinical studies demonstrated 
improved cartilage regeneration thanks to the implantation of 
biomaterials after bone marrow stimulation, but there is still space 
for improvement regarding clinical outcome and tissue quality. The 
autologous chondrocyte implantation (ACI) is a surgical approach 
used to treat full-thickness cartilage defects mainly in knee joints. 
Small samples of normal cartilage with chondrocytes is collected from 
the damaged joint. The cells are cultured in special laboratories to 
increase their number and reimplanted a few weeks later into the areas 
of cartilage damage. The aim of this procedure is to restore normal 
hyaline cartilage to the bones extremities and thereby restore normal 
joint function. The hope is that the stem cells from the marrow will 
differentiate into chondrocytes that will then produce new cartilage 
[9]. Filardo et al. described the implantation of an osteochondral 
biomimetic scaffold consisting of a type I collagen cartilage-like layer, 
a type I collagen/hydroxyapatite intermediate layer, and a mineralized 
blend of type I collagen and hydroxyapatite as a subchondral bone 
compartment, to treat patients with osteochondritis dissecans. Clinical 
scores improved significantly in these patients after the first two years 
and evaluation by MRI indicated good defect filling and implant 
integration, but also heterogeneous tissue regeneration and changes in 
the subchondral bone [10]. Chen et al directly compare the early repair 
response of cartilage defects in different anatomic locations using a 
bilateral model with defects created in both trochlea (TR) and medial 
femoral condyle (MFC). They found that bone marrow stimulation 
induced greater chondrogenesis in TR vs MFC defects in adult rabbits 
[11]. Furthermore Constance et al. underlined how cartilage tissue 
engineering is an interesting method with consistent regenerative 
potential to form a durable hyaline repair cartilage [12]. A variety of 
scaffolds, in combination with chondrogenic cells, have been shown to 
have good ability to regenerate hyaline cartilage both experimentally 
and clinically. 
Therefore several studies have shown that new cartilage can be 
engineered in vivo by transplanting chondrocytes seeded into a three-
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dimensional scaffold. These studies demonstrated that a novel scaffold 
has mechanical properties that can be comparable to native cartilage 
and could be used to repair large osteochondral joints defects. However 
longer outcomes term are required in order to best select the proper 
treatment for osteoarthritis.
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